Table 3

Prevalence of the metabolic syndrome (MS) and its determinants by sex as defined by the IDF and NCEP ATP III criteria
Determinants of MS Prevalence of metabolic syndrome components (%)
IDF NCEP ATP III
All (206) Male (102) Female (104) p All (206) Male (102) Female (104) p-values
Central Obesity 55.3 22.5 87.5 <0.001 31.1 3.9 57.7 <0.001
High BP 39.5 39.0 40.0 0.896 39.5 39.0 40.0 0.896
High FPG 12.1 11.8 12.5 0.872 5.3 5.9 4.8 0.732
Low HDL-C 42.7 32.3 52.5 0.005 42.7 32.3 52.5 0.005
High TG 10.4 9.7 11.1 0.745 10.4 9.7 11.1 0.745
MS 35.9 15.7 55.8 <0.001 15.0 5.9 24.0 <0.001

p- Values (2-tailed): comparing males and females; Central Obesity= IDF {WC≥94cm in males, ≥80cm in females} and NCEP ATPIII {WC>102cm in males, >88cm in females}.

High BP= IDF and NCEP ATPIII {SBP≥130mmHg, DBP≥85mmHg}.

High FPG= IDF {FPG≥100mg/dl}, NCEP ATPIII {FPG≥110mg/dl}.

Low HDL-C= IDF and NCEP ATPIII {HDL <40mg/dl in males, <50mg/dl in females}.

High TG= IDF and NCEP ATPIII {TG≥150mg/dl}.

MS= IDF (International Diabetes Federation) {central obesity and at least two of the following: low HDL-C (or treatment for low HDL-C), high TG (or treatment for high TG), high BP (or treatment for high BP) and high FPG (or treatment for high FPG)}.

MS= NCEP ATP III (National Cholesterol Education Program Adult Treatment Panel III) { at least three of the following: central obesity, high TG, low HDL-C, high BP and high FPG}.

Gyakobo et al.

Gyakobo et al. BMC Endocrine Disorders 2012 12:25   doi:10.1186/1472-6823-12-25

Open Data